Baird Medical Investment Holdings Limited (BDMDW)
| Market Cap | 25.33M -87.3% |
| Revenue (ttm) | 24.49M -39.2% |
| Net Income | -15.95M |
| EPS | -0.53 |
| Shares Out | 32.00M |
| PE Ratio | n/a |
| Forward PE | 5.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 0.0302 |
| Day's Range | n/a |
| 52-Week Range | 0.0300 - 0.1874 |
| Beta | -1.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 3, 2026 |
About BDMDW
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distribu... [Read more]
Full Company ProfileNews
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (“Baird Medical” or the “Company”) (NASDAQ: BDMD), a medical device company focused on the development and commercial...
Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medical” or the “Company”) (Nasdaq: BDMD), a global medical technology company focused on the development...
Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Revenue increase driven by significant growth in the United States and other strategic markets Revenue increase driven by significant growth in the United States and other strategic markets
Baird Medical microwave ablation system, needle receive Pakistan registrations
Baird Medical (BDMD) announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakist...
Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), announced that the BD-GT Microwave Ablation System and T-1610 Disp...
Baird Medical, Tianjin Yuanshan Medical enter cooperation agreement
Baird Medical (BDMD) and Tianjin Yuanshan Medical announced the signing of a strategic cooperation agreement to establish a long-term partnership focused on global development and commercialization of...
Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”) and Tianjin Yuanshan Medical Technology Co., Ltd., operating under ...
Baird Medical completes procedures using MWA technology in Vietnam, Argentina
Baird Medical (BDMD) announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina.
Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina
First procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investme...
Baird Medical relocates global headquarters to New York City
Baird Medical (BDMD) announced the relocation of its global headquarters to the U.S., with the establishment of a new corporate office in New York, NY. The relocation follows the December…
Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion
Enhanced U.S. Presence Centralizes Operations as Company Executes Global Growth Strategy NEW YORK, June 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" o...
Baird Medical files $50M mixed securities shelf
09:04 EDT Baird Medical (BDMD) files $50M mixed securities shelf
Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update
Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China Advancing global expansion with appointment of seasoned commercial leader, Mark Saxton, as CEO of Baird Me...
Baird Medical announces execution of two training shops in Indonesia
Baird Medical (BDMD) Investment announced the successful execution of two clinical training workshops in Indonesia. This initiative supports the Company’s strategic expansion in Southeast Asia by prov...
Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia
NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Expands Global Reach with Regulatory Clearance in Argentina
NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Registration of AI-Driven Surgical Software
NEW YORK, March 4, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announ...
Baird Medical Accelerates U.S. Expansion at NASOIE 2026
NEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technolo...
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...